DPA
regulation of inflammatory arthritis
RA treatment
dysbiotic microbiota
intestinal microbiota
rheumatoid arthritis
production of RvDn
novel hypothesis
local inflammatory responses
therapeutic potential of RvDn
early RA-detection
protective actions of RvDn
mechanisms of pathobiont
pathobiont-induced gut-dysbiosis
chronic inflammatory disease
novel therapeutic opportunities
chronicity of local inflammation
exacerbated inflammation
arthritic inflammation
novel family of host protective LM
potential novel diagnostic markers
regulation of tissue LM profiles
pathobionts
effects
addition
proposed work
treatment options
underlying mechanisms
regulation of pro-resolving lipid mediators
gut barrier function
docosapentaenoic acid-derived Resolvins
termed n
levels
Prevotella copri
considerable socioeconomic impact
plasma
patients
role of Porphyromonas gingivalis
associations
exacerbation
Recent studies
immunosuppression
mice
multi-pronged approach
insights